Chemtrade Logistics Income 6 50 Convertible Unsecured Subordinated Debentures T.CHE.DB.E

Alternate Symbol(s): CGIFF | T.CHE.UN | T.CHE.DB.G | T.CHE.DB.H

Chemicals Basic Materials

Chemtrade Logistics Income Fund is a Canada-based company that operates a diversified business providing industrial chemicals and services to customers in North America and around the world. The Company's segments include Sulphur and Water Chemicals (SWC), and Electrochemicals (EC). SWC segment markets, removes and/or produces merchant, Regen and sulphuric acid, sodium hydrosulphite, elemental sulphur, liquid sulphur dioxide, hydrogen sulphide, sodium bisulphite, and sulphides, and provides other processing services. This segment also manufactures and markets a variety of inorganic coagulants used in water treatment, including aluminum sulphate, and a number of specialty chemicals, including sodium nitrite. EC segment manufactures and markets sodium chlorate and chlor-alkali products including caustic soda, chlorine and HCl, largely for the pulp and paper, oil and gas and water treatment industries. These products are marketed primarily to North American and South American customers.

TSX:CHE.DB.E - Post by User

Chemtrade Logistics Income 6 50 Convertible Unsecured Subordinated Debentures

Bullboard Posts

Comment by Khersonon May 28, 2019 10:52pm

78 Views

Post# 29780459

RE:RE:Desjardins downgrade

Kherson wrote:

hawk35 wrote: Desjardins expects Q1 and Q2 to dissapoint investors.

In light of Chemtrade Logistics Income Fund’s (CHE-UN-T) disappointing fourth-quarter performance, Desjardins Securities analyst David Newman said he’s “moving to the sidelines.”

Chemtrade reported fourth-quarter performance on Thursday, coming up short of estimates on earnings before interest, taxes, depreciation and amortization on all three of its business segments: sulphur products and performance chemicals, water solutions and specialty chemicals, and electrochemicals.

“While a turnaround plan is underway, we are cautious about Chemtrade’s near-term prospects given ongoing operational challenges, a lack of catalysts, limited visibility, stubbornly high Street estimates and constrained deleveraging opportunities over the next 12 months,” Mr. Newman said.

While Chemtrade’s shares are trading at a valuation that could appeal to deep-value investors, “we believe CHE’s near-term growth prospects should remain weak,” the analyst said. High earnings expectations are setting the company up to disappoint investors in the first two quarters of 2019, he added.

Mr. Newman lowered his rating on the stock to “hold” from “buy” and cut his target price to $11.50 from $14.